Contribution of hypoxia-inducible factor-1α to transcriptional regulation of vascular endothelial growth factor in bovine developing luteal cells

Animal Science Journal

Volumn 82, Issue 2, 2011, Pages 244-250

  Zhang, Zhenghong ^a,b   Yin, Dingzhong ^a   Wang, Zhengchao ^b  

^a ANHUI SCIENCE AND TECHNOLOGY UNIVERSITY   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Hypoxia inducible factor 1 ; Luteal cells; Vascular endothelial growth factor

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; COBALT; COBALT CHLORIDE; DEFEROXAMINE; FERROUS AMMONIUM SULFATE; FERROUS ION; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUPEPTIN; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; QUATERNARY AMMONIUM DERIVATIVE; VASCULOTROPIN A;

ANIMAL; ARTICLE; CATTLE; CELL HYPOXIA; FEMALE; GENETIC TRANSCRIPTION; GENETICS; LUTEAL CELL; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELL HYPOXIA; COBALT; DEFEROXAMINE; FEMALE; FERROUS COMPOUNDS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUPEPTINS; LUTEAL CELLS; OLIGODEOXYRIBONUCLEOTIDES; QUATERNARY AMMONIUM COMPOUNDS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE; MAMMALIA;

EID: 79953044473     PISSN: 13443941     EISSN: 17400929     Source Type: Journal    
DOI: 10.1111/j.1740-0929.2010.00832.x     Document Type: Article

References (37)

1. Alam H, Weck J, Maizels E, Park Y, Lee EJ, Ashcroft M, Hunzicker-Dunn M. 2009. Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology 150, 915-928.
2. Amselgruber WM, Schäfer M, Sinowatz F. 1999. Angiogenesis in the bovine corpus luteum: an immunocytochemical and ultrastructural study. Omia, Histologia, Embryologia 28, 157-166.
3. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. 2000. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biology of Reproduction 63, 1106-1114.
4. Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, Jabbour HN, Hirani N. 2006. Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147, 744-753.
5. Duncan WC, van den Driesche S, Fraser HM. 2008. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum. Endocrinology 149, 3313-3320.
6. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA, Bicknell R. 2000. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141, 995-1000.
7. Fraser HM, Duncan WC. 2005. Vascular morphogenesis in the primate ovary. Angiogenesis 8, 101-116.
8. Fraser HM, Wilson H, Morris KD, Swanston I, Wiegand SJ. 2005. Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque. The Journal of Clinical Endocrinology and Metabolism 90, 5811-5818.
9. Fraser HM, Wilson H, Wulff C, Rudge JS, Wiegand SJ. 2006. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reproduction 132, 589-600.
10. Gabler C, Plath-Gabler A, Killian GJ, Berisha B, Schams D. 2004. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol. Reproduction in Domestic Animals 39, 321-327.
11. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. 2008. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertility and Sterility 89, 922-926.
12. Huang LE, Gu J, Schau M, Bunn HF. 1998. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America 95, 7987-7992.
13. Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu X, Yu Y, Zha X, Feng Y. 2008. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Cell Research 18, 780-791.
14. Kaczmarek MM, Schams D, Ziecik AJ. 2005. Role of vascular endothelial growth factor in ovarian physiology. Reproductive Biology 5, 111-136.
15. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. The Journal of Biological Chemistry 274, 6519-6525.
16. Kazi AA, Jones JM, Koos RD. 2005. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Molecular Endocrinology 19, 2006-2019.
17. Kazi AA, Koos RD. 2007. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 148, 2363-2374.
18. Kim J, Bagchi IC, Bagchi MK. 2009. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology 150, 3392-3400.
19. Miyazawa M, Yasuda M, Fujita M, Kajiwara H, Hirabayashi K, Takekoshi S, Hirasawa T, Murakami M, Ogane N, Kiguchi K, Ishiwata I, Mikami M, Osamura RY. 2009. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathology International 59, 19-27.
20. Molitoris KH, Kazi AA, Koos RD. 2009. Inhibition of oxygen-induced hypoxia-inducible factor-1alpha degradation unmasks estradiol induction of vascular endothelial growth factor expression in ECC-1 cancer cells in vitro. Endocrinology 150, 5405-5414.
21. Morishita R, Higaki J, Tomita N, Ogihara T. 1998. Application of transcription factor 'decoy' strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circulation Research 82, 1023-1028.
22. Nishimura R, Okuda K. 2010. Hypoxia is Important for Establishing Vascularization During Corpus Luteum Formation in Cattle. The Journal of Reproduction and Development 56, 110-116.
23. Nishimura R, Sakumoto R, Tatsukawa Y, Acosta TJ, Okuda K. 2006. Oxygen concentration is an important factor for modulating progesterone synthesis in bovine corpus luteum. Endocrinology 147, 4273-4280.
24. Okuda K, Miyamoto A, Sauerwein H, Schweigert FJ, Schams D. 1992. Evidence for oxytocin receptors in cultured bovine luteal cells. Biology of Reproduction 46, 1001-1006.
25. Redmer DA, Reynolds LP. 1996. Angiogenesis in the ovary. Reviews of Reproduction 1 (3), 182-192.
26. Semenza GL. 2000a. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochemical Pharmacology 59, 47-53.
27. Semenza GL. 2000b. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. Journal of Applied Physiology 88, 1474-1480.
28. Shimizu T, Miyamoto A. 2007. Progesterone induces the expression of vascular endothelial growth factor (VEGF) 120 and Flk-1, its receptor, in bovine granulosa cells. Animal Reproduction Science 102, 228-237.
29. Tesone M, Stouffer RL, Borman SM, Hennebold JD, Molskness TA. 2005. Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective messenger RNA expression in vivo and hypoxia-regulated protein secretion in vitro. Biology of Reproduction 73, 927-934.
30. Tropea A, Miceli F, Minici F, Tiberi F, Orlando M, Gangale MF, Romani F, Catino S, Mancuso S, Navarra P, Lanzone A, Apa R. 2006. Regulation of vascular endothelial growth factor synthesis and release by human luteal cells in vitro. The Journal of Clinical Endocrinology and Metabolism 91, 2303-2309.
31. van den Driesche S, Myers M, Gay E, Thong KJ, Duncan WC. 2008. HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Molecular Human Reproduction 14, 455-464.
32. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America 92, 5510-5514.
33. Wang GL, Semenza GL. 1993a. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. The Journal of Biological Chemistry 268, 21513-21518.
34. Wang GL, Semenza GL. 1993b. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
35. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxia-inducible factor 1. The Journal of Biological Chemistry 270, 1230-1237.
36. Wenger RH, Rolfs A, Marti HH, Guénet JL, Gassmann M. 1996. Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochemical and Biophysical Research Communications 223, 54-59.
37. Wiener CM, Booth G, Semenza GL. 1996. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochemical and Biophysical Research Communications 225, 485-488.